ACLAIRO

Aclairo Pharmaceutical Development Group

@aclairo_pharmaceutical_development_group_inc.

Sterling, Virginia
http://www.Aclairo.com
Biotechnology Research

Overview

About Aclairo Pharmaceutical Development Group

Aclairo’s experience as FDA supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities of pharmaceutical drug development. The Aclairo advantage is our experience-based approach to providing strategic, scientific review and regulatory services. This has proven to be our greatest asset in focusing and streamlining our clients’ development efforts, reducing both time and costs.

Headquarters

Sterling, Virginia

Website

http://www.Aclairo.com

Company Size

11-50 employees

Industry

Biotechnology Research

Company Type

Privately Held

Founded

2025

Specialties

Regulatory Services, Preclinical Project Management, Scientific Writing, Preclinical ADME, IND Preparation, CTD/eCTD Maintenance, Gap Analyses, Toxicology, Pharmacology, NDA/MAA preparation, cell and gene therapy, small molecule, large molecule, Nonclinical consulting, and TK Analysis and reports

Posts